Analyzing Vaccine Trials in Epidemics with Mild and Asymptomatic Infection. Author(s): Kahn R, Hitchings M, Wang R, Bellan S, Lipsitch M|Journal: Am J Epidemiol|PMID: 30329134| October 2018 Vaccine efficacy against susceptibility to infection (VES), regardless of symptoms, is an important endpoint of vaccine trials for pathogens with…
Competing Effects Of Indirect Protection And Clustering On The Power Of Cluster-Randomized Controlled Vaccine Trials. Author(s): Hitchings MDT, Lipsitch M, Wang R, Bellan SE|Journal: Am J Epidemiol|PMID: 29522080| March 2018
